Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Class A Common Stock · CUSIP: 738920107
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Harraden Circle Investments, LLC
Shares: 150,000 · Class: 0.31%
- Harraden Circle Investors GP, LP
Shares: 133,173 · Class: 0.27%
- Harraden Circle Investors GP, LLC
Shares: 133,173 · Class: 0.27%
- Harraden Circle Investors, LP
Shares: 95,673 · Class: 0.2%
- Harraden Circle Special Opportunities, LP
Shares: 37,500 · Class: 0.08%
- Harraden Circle Strategic Investments, LP
Shares: 0 · Class: 0%
- Frederick V. Fortmiller, Jr.
Shares: 150,000 · Class: 0.31%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072232
- Form type
- SCHEDULE 13G/A
- Filer
- Aspire Biopharma Holdings, Inc.
- CIK
- CIK 1847345
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership